← Back to headlines
Castle Biosciences Projects $340M-$350M Revenue for 2026
Castle Biosciences has outlined its 2026 revenue target, projecting between $340 million and $350 million, supported by the launch of AdvanceAD-Tx.
27 Feb, 01:58 — 27 Feb, 01:58
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Philippine LTFRB Suspends Three TNCs Over Franchise Violations
just now
NFA relaxes palay-buying rules to benefit farmers
just now
Venezuela suspends 19 oil, gas production-sharing contracts signed under Maduro, sources say
5m ago
GoldBod warns licence holders over failure to file monthly gold transaction reports
11m ago